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Abstract
Objectives We used the Global Burden of Disease (GBD)
2015 study results to explore the burden of high body mass
index (BMI) in the Eastern Mediterranean Region (EMR).
Methods We estimated the prevalence of overweight and
obesity among children (2–19 years) and adults
(C20 years) in 1980 and 2015. The burden of disease
related to high BMI was calculated using the GBD com-
parative risk assessment approach.
Results The prevalence of obesity increased for adults
from 15.1% (95% UI 13.4–16.9) in 1980 to 20.7% (95% UI
18.8–22.8) in 2015. It increased from 4.1% (95% UI
2.9–5.5) to 4.9% (95% UI 3.6–6.4) for the same period
among children. In 2015, there were 417,115 deaths and
14,448,548 disability-adjusted life years (DALYs)
attributable to high BMI in EMR, which constitute about
10 and 6.3% of total deaths and DALYs, respectively, for
all ages.
Conclusions This is the first study to estimate trends in
obesity burden for the EMR from 1980 to 2015. We call for
EMR countries to invest more resources in prevention and
health promotion efforts to reduce this burden.
Keywords Obesity  Burden of disease  Eastern
Mediterranean Region
Introduction
High body mass index (BMI), or overweight, is associated
with increased morbidity and mortality, and is a major risk
factor for diabetes, cancer, cardiovascular diseases, sleep
apnea, and poor physical health (Kim et al. 2016; Yao et al.
2017; Kelly et al. 2017; Mehta et al. 2017). It is also
associated with an increased risk for psychiatric disorders,
including depression (Pratt and Brody 2014; Abou Abbas
et al. 2015). A continuous rise in obesity is threatening
health improvements in many countries (Sidney et al. 2016;
GBD 2015 Obesity Collaborators 2017), while controlling
its spread could drastically improve population health
(Maciosek et al. 2017).
The increase in overweight and obesity prevalence is a
direct result of lifestyle changes due to the social and
demographic transition that started several decades ago
(Broyles et al. 2015; Mokdad et al. 2016). The Eastern
Mediterranean Region (EMR) is facing the same chal-
lenges due to rapid economic, demographic, and lifestyle
changes, including changes in food consumption, reduced
physical activity, and increased sedentary lifestyle (Mu-
saiger et al. 2012; Mokdad et al. 2016). The contribution of
high BMI to total DALYs in the EMR had increased in
2013 (7.5% of DALYs) in comparison to 1990 (3.7% of
DALYs) (Mokdad et al. 2016). Kuwait, Qatar, and Libya,
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three EMR countries, were among the top ten countries
with highest prevalence of obesity worldwide in 2013, and
the man believed to be the heaviest living person was
diagnosed in Saudi Arabia (Ng et al. 2014; Terkawi et al.
2014).
The EMR has a population of about 583 million people
(World Health Organization 2016). Countries in the EMR
vary significantly in terms of their gross domestic product,
socio-demographic profiles, health indicators, and health
system capacities and coverage. Despite the heavy burden
of high BMI in the region, no comprehensive and current
estimates of the epidemic exist for the EMR.
To quantify the burden of high BMI in the EMR and its
impact on health, we systematically evaluated the trends in
prevalence of overweight and obesity as well as the pat-
terns of deaths and DALYs related to high BMI by age and
sex, using the results of the Global Burden of Disease
(GBD) 2015 study. We also estimated the
attributable fraction of high BMI to ischemic heart disease,
stroke, and diabetes mellitus, the three leading non-com-
municable causes of death in EMR, for which high BMI is
a risk factor.
Methods
The prevalence of overweight and obesity among children
(2–19 years) and adults (C20 years) in 1980 and 2015 was
estimated for EMR countries. The EMR countries, based
on the World Health Organization classification, are
Afghanistan, the Kingdom of Bahrain, Djibouti, the Arab
Republic of Egypt, the Islamic Republic of Iran, the
Republic of Iraq, the Hashemite Kingdom of Jordan, the
State of Kuwait, the State of Lebanon, the State of Libya,
the Kingdom of Morocco, the Sultanate of Oman, the
Islamic Republic of Pakistan, Palestine, the State of Qatar,
the Kingdom of Saudi Arabia, the Federal Republic of
Somalia, the Republic of Sudan, the Syrian Arab Republic,
the Republic of Tunisia, the United Arab Emirates, and the
Republic of Yemen.
The burden of disease related to high BMI was calcu-
lated using the GBD comparative risk assessment approach
between 1990 and 2015 (Forouzanfar et al. 2015, 2016). A
detailed methodology of BMI estimation for GBD 2015 has
been published elsewhere (GBD 2015 Obesity Collabora-
tors 2017). Since burden estimations depend on GBD all-
cause mortality, burden of high BMI is only available for
the period 1990–2015. We used all available data surveys
following a systematic search. The search strategy as well
as data sources used per country have been published as an
appendix elsewhere and are available from the Global
Health Data Exchange (Institute for Health Metrics and
Evaluation 2016; GBD 2015 Obesity Collaborators 2017).
Briefly, Medline was systematically searched for studies
providing nationally or subnationally representative esti-
mates of overweight prevalence, obesity prevalence, or
mean body mass index (BMI) published between 1 January
2014 and 31 December 2015 to update the GBD 2013
systematic literature search (Ng et al. 2016).
For adults, 127 out of 2036 abstracts identified met
inclusion criteria and were extracted. For children, 146 out
of 971 articles identified were extracted. In total, 816
articles were included in the analysis. Additionally, the
Global Health Data Exchange (GHDx) database was
searched for individual-level data from major multinational
survey series or country-specific surveys and identified
1026 unique sources meeting the inclusion criteria. Of the
816 articles and 1026 unique sources, all those pertaining
to EMR countries were included. The GBD 2015 results
tool from the GHDx allows readers to view, country by
country, what data sources have been used to produce these
estimates (Institute for Health Metrics and Evaluation
2016).
For adults, overweight was defined as
25.0 B BMI B 30 kg/m2, and obesity was defined as BMI
C30 kg/m2. The International Obesity Task Force defini-
tion was used for childhood overweight and obesity (Cole
et al. 2000).
Children were defined as individuals 2–19 years of age
based on the lowest age for which the International Obesity
Task Force provides a definition of overweight and obesity,
and the age groups used in GBD modeling, which include
19 in the age group 15–19 (Cole et al. 2000; Wang et al.
2016).
Briefly, a spatiotemporal Gaussian process regression
(ST-GPR) was used to estimate the mean prevalence of
overweight and obesity (Ng et al. 2014). To improve
estimates for countries with sparse data, three country-level
covariates with best fit and coefficients in the expected
direction were selected: 10-year lag-distributed energy
intake per capita, the absolute latitude of the country as
proxy for income, and the proportion of people living in
urban areas. These covariates have been systematically
evaluated in a previous study (Ng et al. 2014).
The Bradford Hill criteria for causation and the World
Cancer Research Fund evidence grading criteria were used
to systematically evaluate epidemiologic evidence sup-
porting the causal relationship between high BMI and
various diseases among adults (C20 years of age) (Hill
1965; World Cancer Research Fund and American Institute
for Cancer Research 2007).
The population-attributable fraction by country, age,
sex, and year was calculated to quantify the burden of
disease related to high BMI, defined as BMI C25 kg/m2,
for each disease. Deaths and DALYs related to high BMI
for each country, age, sex, year, and cause were computed
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by multiplying the population-attributable fraction by the
total deaths or DALYs estimated in GBD 2015 for that
country, age, sex, year, and cause. The total disease burden
of high BMI was calculated as the sum of disease-specific
burden.
95% uncertainty intervals (UI) for all results were
computed using Monte Carlo simulations, keeping 1000
draws of each quantity of interest to propagate uncertainty
into final estimates.
Expected estimates were also produced for each country
based on its Socio-demographic Index (SDI)—a summary
measure of lag-distributed income per capita, average
educational attainment over the age of 15 years, and total
fertility rate (Forouzanfar et al. 2015). In GBD 2015, SDI
was computed by rescaling each component to a scale of
zero to one, with zero being the lowest observed educa-
tional attainment, lowest income per capita, and highest
fertility rate from 1980 to 2015, and one being the highest
observed educational attainment, highest income per cap-
ita, and lowest fertility rate during that time, and then
taking the geometric mean of these values for each loca-
tion-year.
This study followed the Guidelines for Accurate and
Transparent Health Estimates Reporting (GATHER) of the
World Health Organization (WHO) regarding documenta-
tion of data sources, estimation methods, and statistical
analysis (Stevens et al. 2016).
Role of the funding source
The Bill & Melinda Gates Foundation had no role in the
development of these methods.
Results
The mean BMI increased from 25.2 kg/m2 [95% uncer-
tainty interval (UI) 24.9–25.5] in 1980 to 26.0 kg/m2 (95%
UI 25.8–26.3) in 2015 in the EMR among persons aged
20 years or older. The prevalence of obesity increased from
15.1% (95% UI 13.4–16.9) to 20.7% (95% UI 18.8–22.8)
for the same period and for the same age group (Fig. 1). It
increased from 4.1% (95% UI 2.9–5.5) to 4.9% (95% UI
3.6–6.4) for the same period among those aged 2–19 years
(Fig. 1). The highest prevalence of obesity among adults
20 years or older in 2015 was observed in Qatar: 42.5%
(95% UI 40.1–44.8) for males and 52.4% (95% UI
50.3–54.5) for females (e-Table 1); and the highest for
children 2–19 years was observed in Kuwait: 22.1% (95%
UI 17.8–27.0) for males and 19.2% (95% UI 15.2–23.4) for
females (e-Table 2). The lowest prevalence of obesity was
observed in Somalia among individuals 20 years or older:
2.5% (95% UI 1.5–4.0) for males and 10.5% (95% UI
8.3–12.8) for females (e-Table 1), and in Yemen and
Pakistan for children 2–19 years of age: 1.3% (95% UI
0.9–1.8) for males in Yemen and 2.2% (95% UI 1.4–3.3)
for females in Pakistan (e-Table 2). Prevalence of obesity
was higher in females than males 20 years or older for all
countries, with Sudan having the highest difference
between sexes: 11.4% (95% UI 10.0–13.1) for males and
28.3% (95% UI 25.6–31.2) for females (e-Table 1). The
highest difference in obesity prevalence between sexes for
children was observed in Qatar: 20.8% (95% UI 16.5–25.1)
for males and 13.5% (95% UI 10.3–17.1) for females. In
children, prevalence of obesity was higher in males for
several countries (e-Table 2).
Deaths
In 2015, there were 417,115 deaths attributable to high
BMI in EMR, which constitute about 10% of total deaths in
the region for all ages. This is a rate of 120.1 (95% UI
87.5–156.2) deaths per 100,000 population, an 11%
increase since 1990. It contributed to 5.0, 0.9, and 1.9% of
all deaths cause by ischemic heart disease, ischemic stroke,
and diabetes mellitus, respectively. Contribution by speci-
fic age groups is detailed in Table 1. In 2015, the rate of
deaths attributable to high BMI was highest in Afghanistan,
227.6 (95% UI 146.2–319.5), and lowest in Tunisia, 64.8
(95% UI 42.7–92.5) per 100,000 population (Table 2).
Overall, death rates attributable to high BMI have
increased in 11 countries and decreased in 11 (Table 2).
The largest increase in deaths per 100,000 population
attributable to high BMI was observed in Djibouti: from
37.3 (95% UI 15.1–70.6) in 1990 to 101.1 (95% UI
47.5–192.7) in 2015 (Table 2). The largest decrease was
observed in Lebanon: from 124.8 (95% UI 85.2–169.7) in
1990 to 72.5 (95% UI 47.0–101.0) in 2015 (Table 2).
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Fig. 1 Prevalence of obesity among adults aged 20 years or older
and children aged 2–19 years in 1980 and 2015 (Global Burden of
Disease 2015 study, Eastern Mediterranean Countries, 1980 and
2015)
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DALYs
In 2015, there were 14,448,548 DALYs attributable to high
BMI in the EMR, which constitutes about 6.3% of total DALYs
in the region for all ages. This is a rate of 3452.5 (95% UI
2599.2–4386.5) DALYs per 100,000 population, a 13.9%
increase since 1990. It contributed to 3.0, 0.5, and 2.3% of all
DALYs caused by ischemic heart disease, stroke, and diabetes
mellitus, respectively. Contribution by specific age groups is
detailed in Table 3. In 2015, the rate of DALYs attributable to
high BMI was highest in Afghanistan, 6576.7 (95% UI
4366.1–9219.6), and lowest in Tunisia, 2022.4 (95% UI
1395.1–2724.3) per 100,000 population. Trends in DALYs
followed trends in deaths from high BMI in all countries. The
largest increase in DALYs per 100,000 population attributable
to high BMI was observed in Djibouti: from 1111.0 (95% UI
492.8–2005.8) in 1990 to 2810.8 (95% UI 1432.5–5212.9) in
2015 (Table 4). The largest decrease was observed in Lebanon:
from 3552.4 (95% UI 2508.2–4645.4) in 1990 to 2363.8 (95%
UI 1707.9–3077.2) in 2015.
Expected versus observed
Overall, and based on an SDI of 0.55, a death rate of 74.0
and a DALYs rate of 2114.3 per 100,000 population were
expected for the EMR in 2015 for high BMI. Both are
lower than the observed death rate of 120.1 (95% UI
87.5–156.2) and DALYs rate of 3452.5 (95% UI
2599.2–4386.5) for the same year. Expected estimates for
each country are detailed in Tables 3 and 4.
Discussion
This is the first study to provide estimates of trends in
obesity prevalence, deaths, and DALYs for the EMR from
1980 to 2015. Our study showed that the observed burden
for high BMI was higher than expected for most countries
in the region based on their SDI levels. Our study calls for
renewed efforts to reduce the burden of obesity in the
region. Indeed, with further progression of the epidemio-
logic transition and the growth and aging of the EMR
population, high BMI will increase the burden of chronic
conditions and disability and put financial and resource
strains on the health systems.
High BMI is observed in some poor and rich countries
of the EMR. In developed countries such as the United
States and France, obesity is higher among low socioeco-
nomic strata of the population (Drewnowski et al. 2014).
These patterns in the West are attributable to poor diet and
lower physical activity levels. Previous studies have
reported similar findings for both socioeconomic status and
sex in the EMR (Musaiger 2011a). In the EMR, except for
Iran and Lebanon, all high-middle- and high-SDI countries
had an obesity prevalence equaling or exceeding 25% for
both males and females 20 years or older. Obesity preva-
lence exceeded 10% among children 2–19 years only in
these countries as well, except for Bahrain, Jordan, Leba-
non, and Iran. Djibouti and Egypt were the only low- and
middle-SDI countries where childhood obesity exceeded
10% for females. These country-level estimates might be
masking variations of the epidemic within each of the
countries. Indeed, few studies have been done at the
country level in the EMR, and these showed a variation in
BMI levels between levels of education and income. High
BMI was more likely to impact those with low educational
levels (Sibai et al. 2003; Memish 2014).
Unfortunately, our estimations for observed obesity
burden were higher than expected for the region, and based
on SDI, which only deals with socioeconomic inequalities
between countries. However, the biggest gaps between the
included countries are cultural factors and obesogenic
cultural traditions, as well as political instability (wars,
civil unrest,) all of which are linked to obesity but not
Table 1 Deaths, with 95% uncertainty intervals (UI), per 100,000
population attributable to high body mass index among those who
died from ischemic heart disease, stroke, and diabetes, by age groups
(Global Burden of Disease 2015 study, Eastern Mediterranean
countries, 1990 and 2015)
Age Cause 1990 2015
Males Females Males Females
15–49 Ischemic heart disease 10.1 (6.0–14.7) 7.0 (4.5–9.5) 12.1 (7.6–17.2) 6.9 (4.7–9.3)
Stroke 7.1 (4.6–9.8) 8.1 (5.8–10.6) 7.2 (4.7–9.9) 7.3 (5.3–9.6)
Diabetes 1.7 (1.2–2.3) 2.0 (1.5–2.6) 2.6 (1.8–3.3) 2.9 (2.2–3.6)
50–69 Ischemic heart disease 118.4 (67.9–177.4) 118.1 (80.0–161.8) 134.4 (82.3–191.6) 107.1 (74.8–142.7)
Stroke 58.1 (33.6–85.1) 77.8 (53.9–107.7) 60.6 (38.4–85.5) 68.7 (49.1–91.2)
Diabetes 24.8 (15.7–34.4) 36.4 (25.1–50.1) 39.2 (27.2–52.3) 53.4 (40.6–67.8)
70? Ischemic heart disease 283.8 (141.5–460.9) 366.1 (225.5–539.6) 336.9 (183.3–532.9) 361.0 (222.4–520.7)
Stroke 117.4 (58.4–198.2) 163.6 (96.9–248.3) 125.8 (65.8–203.8) 150.7 (89.1–223.9)
Diabetes 57.7 (30.8–89.2) 81.9 (47.6–130.2) 106.5 (59.1–163.1) 160.3 (103.1–224.8)
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measured by SDI (Ulijaszek 2007). Cultural factors and
obesogenic cultural traditions disproportionally affect
women, highlighting cross-cutting gender issues in
women’s health (Shapira 2013). This might explain the
observed gender differences in overweight and obesity.
Similarly, social determinants of health in countries in
conflict tend to differ as morbidity and mortality are
associated with conflict (World Health Organization 2008).
More importantly, wars and civil unrest are closely asso-
ciated with child malnutrition, which in turn is associated
with increased risk of obesity, hypertension, cardiovascular
disease, and type 2 diabetes (Devakumar et al. 2014;
Charchuk et al. 2015). This leads to the intergenerational
effects of war on obesity and the doubled burden of
undernutrition in countries affected by wars or experienc-
ing chronic civil unrest (Devakumar et al. 2014).
Despite this increase in obesity, EMR countries can
hope to control their epidemic as declines in obesity
prevalence have been reported in other countries due to
health interventions and environmental and policy changes
(Schmidt Morgen et al. 2013; Keane et al. 2014). EMR
countries can benefit from implementing an array of proven
interventions to control their obesity epidemics. Over the
last decade, very few EMR ministries of health have
focused on health promotion strategies to reduce obesity,
such as awareness and behavioral changes. Of the 22
countries in the EMR, only Bahrain, Qatar, and Saudi
Arabia had substantial information on combating obesity
on their ministry of health websites (Gharib et al. 2012;
Saudi Ministry of Health 2012). Qatar and Saudi Arabia
launched national campaigns against obesity in 2011 and
2012, respectively. The Saudi campaign focused primarily
on dietary awareness, promoting healthy eating choices and
emphasizing variety and balance through a food pyramid
(Hamad Al-Dkheel 2012). The Qatar campaign was more
comprehensive, setting up programs to increase physical
activity, replace school snacks with healthier options, and
pilot a nutrition surveillance system in addition to a dietary
awareness campaign (Mohammed Al-Thani 2011). Indeed,
and despite the campaign in Qatar, obesity prevalence is
one of the highest in the region, suggesting the need for a
more aggressive approach.
Promoting healthier lifestyles around nutrition and
physical activity is greatly needed in this region. As
pointed out previously, possible factors determining obe-
sity in the EMR include nutrition transition, inactivity,
urbanization, marital status, a shorter duration of breast-
feeding, frequent snacking, skipping breakfast, a high
intake of sugary beverages, an increase in the incidence of
eating outside the home, long periods of time spent view-
ing television, massive marketing promotion of high-fat
foods, stunting, perceived body image, cultural elements,
and food subsidy policies (Musaiger 2011b).
Indeed, estimates from the GBD study show an increase
in dietary risk factors and low levels of physical activity
(Forouzanfar et al. 2016). What the EMR populations
consume can be directly affected by national policies,
specifically those around food economics. For instance, in
many EMR countries such as Egypt, Morocco, and Saudi
Arabia, governments subsidize grains, bread, wheat flour,
sugar, and cooking oil, and impose taxes on imported foods
(Asfaw 2007; Musaiger 2011b). However, fruits and veg-
etables are neither subsidized nor exempt from import
taxes, making healthier food choices harder for the popu-
lation. As for physical activity, the lack of exercise facil-
ities has been reported, at least in Egypt and Saudi Arabia,
as the main reason for low physical activity (Al-Rafaee and
Al-Hazzaa 2001; El-Gilany et al. 2011).
This study has a few limitations. These include possible
underestimation of the prevalence of obesity or disease
burden from high BMI as self-reported height and weight
data were used. However, we corrected these based on
measured data at each age, sex, and country unit (GBD
2015 Obesity Collaborators 2017). Briefly, no significant
difference between measured and self-reported data for
children was found. For adults, self-reported data were
adjusted for overweight prevalence, obesity prevalence,
and mean BMI using nested hierarchical mixed-effects
regression models, fit using restricted maximum likelihood
separately by sex. Second, estimates for some countries
with sparse data were driven by covariates in the statistical
modeling. This, in fact, highlights the need for more timely
surveillance data on BMI and risk factors in the EMR.
Better quality data in the EMR for quantification of mor-
bidity and mortality burden and health policy planning is
urgently needed. Third, the attributable effect of BMI on
ischemic heart disease, stroke, and diabetes was derived
from prospective observational studies and meta-analyses,
and hence does not account for differences by ethnicity, or
for underlying diseases (Global BMI Mortality Collabora-
tion et al. 2016). While these observational studies are not
specifically from the EMR, the attributable effect of BMI
on the three diseases has been shown to remain the same
across different regions from the world (Singh et al. 2013).
Fourth, BMI presents some drawbacks as it is a measure of
excess weight rather excess body fat (Daniels 2009). The
relationship between BMI and body fat can be influenced
by age, sex, ethnicity, and muscle mass. In addition, BMI
does not indicate whether excess weight is due to fat,
muscle, or bone (Daniels 2009). However, BMI is favored
for its ease of use in surveys and is the most available
indicator regarding excess weight. More details on this
study’s limitations are available elsewhere (GBD 2015
Obesity Collaborators 2017).
This study showed that high BMI creates a major burden
in the EMR. We call for countries in the region to invest
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more resources in prevention and health promotion efforts
to reduce the prevalence of obesity. These programs should
focus on stopping weight gain as a first step and more
aggressive programs to reduce weight among those who
need to do so. These programs should take into account the
culture and local environment. Moreover, countries should
join efforts in their programs and policies and share
experiences and success stories.
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